Jupiter Neurosciences, Inc. Common Stock (NASDAQ: JUNS) last traded at $2.85, up 2.89% on the session. The quote above updates while this page is open; the figures below are drawn from Jupiter Neurosciences, Inc. Common Stock’s own filings and are restated only when a new one is published.
Jupiter Neurosciences, Inc. Common Stock trades on NASDAQ under the ticker JUNS. Its market capitalisation is $2.19 million.
Valuation measures for Jupiter Neurosciences, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $2.19M |
|---|---|
| Price / sales | 100.69 |
| Beta | 1.53 |
Trailing-twelve-month figures tagged in Jupiter Neurosciences, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $21.8K |
|---|---|
| Net income (TTM) |
|---|
| -$9.20M |
| Gross margin | 80.59% |
|---|
| Operating margin | -45016.44% |
|---|
Range and volume for JUNS over the past 52 weeks.
| 52-week high | $135.75 |
|---|---|
| 52-week low | $2.25 |
| Volume | 7.4K |
| Average volume | 968.1K |
| Previous close | $2.77 |
Invest a chosen dollar amount in Jupiter Neurosciences, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell JUNS.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.